Industry subject matter experts spoke about the challenges of turning complex molecules into medicines patients can reliably use.
|Articles|December 1, 2010
AAPS 2010 Science Award Winners: Christian Noe
Advertisement
A Joint Presentation of Pharmaceutical Technology and
Interviews with the 2010 AAPS Science Award Winners
Dr. Christian Noe
Professor, University of Vienna.
Award: 2010 PSWC Research Achievement Award for work in drug discovery strategies
View Full Research Presentation
Winners
Listen to the Interviews
AAPS President
Dr. Danny Shen, president of AAPS, discusses the level of scientific innovation and industry trends.
Listen>>
Advertisement
Related to this article
The pharmaceutical supply chain is a complex system with high stakes. USP provides insights on how it is helping industry navigate global disruptions and procurement issues.
Jaenisch, Muraru, and Pandey discuss how regulators will audit pharma against its own AI policies and ways QA and regulatory teams can build defensible, inspection-ready AI practices.
Impurity deficiencies in submissions are remarkably consistent. Subathra Ramamoorthy, Veranova, explains how to catch them before agency filing.
USP’s Sheehan and Liu talk at AAPS PharmSci 360 abou getting novel excipients past the monograph hurdle through early engagement with FDA.
CDMOs announced expansions, exhibitors showcased automated equipment, and supply chain strategy discussions were a focus at CPHI Milan 2026.
Mitigating nitrosamine risk requires assessing each product individually and chasing zero nitrite in pharmaceutical excipients is often impractical and costly.
The business case for regulated AI turns on the cost of producing an outcome that the quality system can accept.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Improving Oral Peptide Delivery Through Structural Modifications
2
Using OEE Monitoring to Justify Expenditure on Aging Production Lines
3
Regulatory Roundup—October 2026: FDA Advances Rare Disease Development and Transparency Efforts
4
RRP Accelerated Approval: What VOCERYQ Means for Manufacturing Teams
5